FindTrial
Sign In

Establishing the Median and 95% Effective Doses of Tegileridine for Immediate Post-Surgical Analgesia Following Totally Extraperitoneal Hernioplasty: A Sequential Dose-Finding Study

Establishing the Median and 95% Effective Doses of Tegileridine for Immediate Post-Surgical Analgesia Following Totally Extraperitoneal Hernioplasty: A Sequential Dose-Finding Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112246
Enrollment
Unknown
Registered
2025-11-11
Start date
2025-11-15
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgesia

Interventions

Taglidine Observation Group:None

Sponsors

Central Hospital of Dalian University of Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ASA Grade I- II; 2. Aged 18 to 65; 3.BMI < 30kg/m ^2; 4. Select a TEP; 5. Subjects who understand the research content are willing to join the study and sign a written informed consent form.

Exclusion criteria

Exclusion criteria: 1.History of chronic pain; 2. Long-term use of opioid drugs, sedatives or antidepressants; 3. Insufficiency of liver or kidney function; 4. Study the history of drug allergies; 5. Inability to communicate or refusal to participate in research.

Design outcomes

Primary

MeasureTime frame
Numerical rating scale score;—

Countries

China

Contacts

Public ContactCongjie Bi

Central Hospital of Dalian University of Technology

congjie.bi@outlook.com+86 135 0425 1513

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026